Stanovisko ČSAT ke Konsenzu EAS 2021: Lipoproteiny bohaté na triglyceridy a jejich remnantní částice – přehled metabolizmu, role při aterosklerotickém kardiovaskulárním onemocnění a nové terapeutické strategie

Investor logo

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Title in English Statement CSAT on Consensus EAS 2021: Triglyceride-rich lipoproteins and their remnants – metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies
Authors

VRABLÍK Michal BLAHA Vladimír CÍFKOVÁ Renata FREIBERGER Tomáš KARÁSEK David KRAML Pavel PIŤHA Jan ROSOLOVÁ Hana SOŠKA Vladimír ŠTULC Tomáš URBANOVÁ Zuzana MAŠKOVÁ Jana

Year of publication 2022
MU Faculty or unit

Faculty of Medicine

Web https://www.atheroreview.eu/casopisy/athero-review/2022-3-25/stanovisko-csat-ke-konsenzu-eas-2021-lipoproteiny-bohate-na-triglyceridy-a-jejich-remnantni-castice-prehled-metabolizmu-role-pri-aterosklerotickem-kardiovaskularnim-onemocneni-a-nove-terapeutic
Attached files
Description In September 2021, an expert consensus on triglyceride-rich lipoproteins and their remnant particles was published in the European Heart Journal. The Committee of the Czech Society for Atherosclerosis (CSAT) developed the following Opinion summarizing the most important information. However, this CSAT Opinion does not replace the full text of the EAS 2021 Consensus. Those interested in the detailed text are encouraged to read the original full text.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.